Many drugs available and in development work by targeting proteins, an approach that comes with limitations. For one, proteins are not the root cause of disease, said Samir Ounzain, co-founder and CEO ...

Eli Lilly’s hunt for obesity targets has led it to the dark genome. The Big Pharma has put together a deal worth up to $1 billion in biobucks to partner with Haya Therapeutics to find multiple ...

The vast non-coding portion of the human genome has had many names, including ‘junk’ and ‘dark matter.’ But research, including the international ENCODE project, has shown that these regions are ...

Princess Haya of Jordan has made her first public appearance since her much-discussed divorce from Dubai's Sheikh, Mohammed bin Rashid Al Maktoum. The Princess attended a horseback riding event ...

Samir Ounzain, PhD, co-founder and CEO of HAYA Therapeutics The noncoding portion that makes up 98% of the human genome is anything but “junk” to HAYA Therapeutics, which said it is partnering with ...

LAUSANNE, Switzerland & SAN DIEGO, May 08, 2025--(BUSINESS WIRE)--HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram ...

LAUSANNE, Switzerland--(BUSINESS WIRE)--HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), announced the successful ...

LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), today announced ...

BAYAMON, P.R. As a daughter of King Hussein and the wife of the ruler of Dubai, Princess Haya bint al-Hussein of Jordan has the pedigree that is practically a prerequisite for presiding over the ...

The ex-wife of the ruler of Dubai has been awarded £554m in Britain's biggest ever divorce settlement. Princess Haya bint Hussein will receive a lump sum payment of £251m as part of a 'clean break' ...